Increasing its effectiveness in treatment is associated with the improvement of the technique of isolation of these cells from tumor tissue [101] using appropriate markers, e.g., co-stimulatory surface receptor CD137 (4-1BB), which appears on T lymphocytes with a high capacity to recognize and respond to neoplastic cells [102]. The gene discussed is TNFRSF9; the disease is neoplasm.